Multicentric, Open Label With Retrospective Inclusion and Follow-up of Acetabular Prothetic Implant "Polymax"
NCT ID: NCT02826187
Last Updated: 2024-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
181 participants
OBSERVATIONAL
2014-07-31
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Improved fixation, reduced wear rates and reduced implant dislocation rates remain subjects of continuous improvement.
Hip implants cemented and cementless are part of therapeutic arsenal of orthopedic surgeons for joint replacement of the defective hip.
The anchor and friction torque are both essential to the survival of hip implants. Therefore acetabular implants without cement with ceramic insert or polyethylene in a metalback or full polyethylene coated with titanium grains without metalback are proposed, but they have their own complications (Squeaking, fractures, recovery difficulties, difficult radiographic analysis, high cost for ceramics, primary stability defects, instability of the instrument set, Titanium residues in absence of metalback. An alternative to these implants may be an acetabular component without cement with polyethylene insert with an end metalback to increase both polyethylene thickness and size of the head in order to expect a low complication rate with important longevity for a lower cost.
This study was conducted to ensure the safety and effectiveness of the acetabular implant "POLYMAX"
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
POLARSTEM Retrospective Multicenter Study
NCT02680340
Evaluation of Implant Survival in Patients With a Pinnacle Ultamet Device in Conventional Total Hip Joint Replacement
NCT01684631
Multicentre SMS Study - FR
NCT06640764
PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty
NCT03372278
A Randomised Single Centre Study to Compare the Long-term Performance of 4 Designs of the DePuy Ultima LX Stem in Primary Total Hip Replacement
NCT00208351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with acetabular implant
Data to be collected are :
* Early complications data related to implant or procedure of implantation
* Late stage complications data
* Efficacity of treatment with HIP score
* Patient satisfaction
* Radiographic evaluation during standard follow-up
Early complications data
Early complications of interest are :
* New arthroplasty for any reason
* Related to the implant :
* Wrong position of the implant
* Early displacement of the implant
* Related to the intervention :
* Hematoma
* Dislocation (or not causing the resumption of joint replacement)
* Deep vein thrombosis
* Pulmonary embolism
* Acute Infection
Late stage complications data
Late complications taken into account are:
* New arthroplasty for any reason
* Aseptic loosening
* Delayed hypersensitivity reaction type IV
* Solid Tumors
* Recurrent dislocation (causing or not the resumption of joint replacement)
* Allergic reactions of any kind
* Chronic infection
Patient Satisfaction
Patient satisfaction evaluated by Womac reduced Score
Efficacity
Efficacity as evaluated by Harris HIP score
Radiographic evaluation
Bone reaction visible in radiography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early complications data
Early complications of interest are :
* New arthroplasty for any reason
* Related to the implant :
* Wrong position of the implant
* Early displacement of the implant
* Related to the intervention :
* Hematoma
* Dislocation (or not causing the resumption of joint replacement)
* Deep vein thrombosis
* Pulmonary embolism
* Acute Infection
Late stage complications data
Late complications taken into account are:
* New arthroplasty for any reason
* Aseptic loosening
* Delayed hypersensitivity reaction type IV
* Solid Tumors
* Recurrent dislocation (causing or not the resumption of joint replacement)
* Allergic reactions of any kind
* Chronic infection
Patient Satisfaction
Patient satisfaction evaluated by Womac reduced Score
Efficacity
Efficacity as evaluated by Harris HIP score
Radiographic evaluation
Bone reaction visible in radiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient having been implanted with a POLYMAX implant;
* Patient having agreed to participate in a follow-up 5 years;
* Patient who have accepted the use of their data in the context of this study.
* Patient having pre-operative and post-operative data
Exclusion Criteria
* Patients not available for follow up at 2 and 5 years ..
* Metabolic disease or autoimmune witch may interfere with bone growth not allowing the indication of a prosthesis without cement,
* Mental disorder or disease of proven behavior.
* Severe osteoporosis,
* Direct or indirect bone irradiation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe CHIRON, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Grégoire Hospital
Saint-Grégoire, , France
Purpan Hospital
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC31/15/7859
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.